Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review
AUTOR(ES)
Kuchay, Mohammad Shafi, Farooqui, Khalid J., Bano, Tarannum, Khandelwal, Manoj, Gill, Harmandeep, Mithal, Ambrish
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
13/02/2017
RESUMO
SUMMARY Severe hypertriglyceridemia accounts for up to 7% of all cases of acute pancreatitis. Heparin and insulin activate lipoprotein lipase (LPL), thereby reducing plasma triglyceride levels. However, the safety and efficacy of heparin and insulin in the treatment of hypertriglyceridemia-associated acute pancreatitis have not been well established yet. We successfully used heparin and insulin as first-line therapy in four consecutive patients with acute pancreatitis secondary to hypertriglyceridemia. In a literature search, we revised almost all reports published to date of patients managed successfully with this combination. Heparin and insulin appear to be a safe, effective, and inexpensive first-line therapy for hypertriglyceridemia-associated acute pancreatitis.
Documentos Relacionados
- Intramural duodenal hematoma secondary to pancreatitis: case report and review of the literature
- Chronic pancreatitis: diagnosis and management of complications
- Retroperitoneal schwannoma: case series and literature review
- Management of acute pancreatitis: Role of antibiotics remains controversial
- Glomangiopericytoma: a case series with review of literature
